Literature DB >> 23707629

Molecular mechanisms of glucocorticoid action in mast cells.

Emmanuel Oppong1, Nesrin Flink, Andrew C B Cato.   

Abstract

Glucocorticoids are compounds that have successfully been used over the years in the treatment of inflammatory disorders. They are known to exhibit their effects through the glucocorticoid receptor (GR) that acts to downregulate the action of proinflammatory transcription factors such as AP-1 and NF-κB. The GR also exerts anti-inflammatory effects through activation of distinct genes. In addition to their anti-inflammatory actions, glucocorticoids are also potent antiallergic compounds that are widely used in conditions such as asthma and anaphylaxis. Nevertheless the mechanism of action of this hormone in these disorders is not known. In this article, we have reviewed reports on the effects of glucocorticoids in mast cells, one of the important immune cells in allergy. Building on the knowledge of the molecular action of glucocorticoids and the GR in the treatment of inflammation in other cell types, we have made suggestions as to the likely mechanisms of action of glucocorticoids in mast cells. We have further identified some important questions and research directions that need to be addressed in future studies to improve the treatment of allergic disorders.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  APC; Allergy; BMMC; DOK 1; DUSP; Doking protein 1; Erk; FITC; GR; GRE; Gab2; Grb2-associated binder 2; IL; IP3; ITAM; IgE; Interleukin; JNK; LAT; MAPK; Mast cells; NTAL; PEP; PI3K; PIP2; PIP3; PLC; PTP; Protein tyrosine phosphatases; SH2 domain containing leukocyte protein of 76kDa; SH2 domain containing polyinositol-5phosphatase 1; SHIP1; SLAP; SLP-76; SYK; Src-like adaptor protein; TNFα; antigen presenting cell; bone marrow derived mast cells; c-Jun N-terminal kinases; dual specificity phosphatase; extracellular regulated kinases; fluorescein isothiocyanate; glucocorticoid receptor; glucocorticoid response elements; immunoglobulin E; immunoreceptor tyrosine based activation motifs; inositol 1,4,5-trisphosphate; linker of activation of T-cells; mitogen-activated protein kinase; non-T-cell activation linker; phosphatidylinositol (3,4,5)-triphosphate; phosphatidylinositol 3-kinase; phosphatidylinositol 4,5-bisphosphate; phospholipase C; proline-, glutamic acid-, serine- and threonine-rich (PEST)-domain enriched tyrosine phosphatase; protein tyrosine phosphatases; spleen tyrosine kinase; tumour necrosis factor

Mesh:

Substances:

Year:  2013        PMID: 23707629     DOI: 10.1016/j.mce.2013.05.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

Review 1.  Immune regulation by glucocorticoids.

Authors:  Derek W Cain; John A Cidlowski
Journal:  Nat Rev Immunol       Date:  2017-02-13       Impact factor: 53.106

Review 2.  Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.

Authors:  Dariusz Szukiewicz; Piotr Wojdasiewicz; Mateusz Watroba; Grzegorz Szewczyk
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

Review 3.  Transcriptional regulation of tenascin genes.

Authors:  Francesca Chiovaro; Ruth Chiquet-Ehrismann; Matthias Chiquet
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

Review 4.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

Review 5.  A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology.

Authors:  Mubashir Ahmad; Yasmine Hachemi; Kevin Paxian; Florian Mengele; Mascha Koenen; Jan Tuckermann
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

6.  High-dose levocetirizine for the treatment of refractory chronic spontaneous urticaria and the effect on the serum inositol triphosphate level.

Authors:  Xianqiong Huang; Zhaoyang Li; Renshan Sun
Journal:  J Int Med Res       Date:  2019-07-25       Impact factor: 1.671

7.  The role of the Annexin-A1/FPR2 system in the regulation of mast cell degranulation provoked by compound 48/80 and in the inhibitory action of nedocromil.

Authors:  Ajantha Sinniah; Samia Yazid; M Perretti; Egle Solito; R J Flower
Journal:  Int Immunopharmacol       Date:  2016-01-21       Impact factor: 4.932

Review 8.  Pharmacological treatment options for mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-30       Impact factor: 3.000

Review 9.  Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.

Authors:  Heather L Caslin; Kasalina N Kiwanuka; Tamara T Haque; Marcela T Taruselli; H Patrick MacKnight; Anuya Paranjape; John J Ryan
Journal:  Front Immunol       Date:  2018-04-26       Impact factor: 7.561

10.  Bioinformatics Analysis of Gene Expression Profiles for Risk Prediction in Patients with Septic Shock.

Authors:  Yingchun Hu; Lingxia Cheng; Wu Zhong; Muhu Chen; Qian Zhang
Journal:  Med Sci Monit       Date:  2019-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.